Caribou Biosciences (CRBU) Competitors $0.85 +0.08 (+10.44%) Closing price 04:00 PM EasternExtended Trading$0.84 -0.01 (-1.33%) As of 07:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CRBU vs. CYRX, ATXS, AQST, AURA, PVLA, ITOS, ACB, CMPX, TSVT, and TERNShould you be buying Caribou Biosciences stock or one of its competitors? The main competitors of Caribou Biosciences include Cryoport (CYRX), Astria Therapeutics (ATXS), Aquestive Therapeutics (AQST), Aura Biosciences (AURA), Palvella Therapeutics (PVLA), iTeos Therapeutics (ITOS), Aurora Cannabis (ACB), Compass Therapeutics (CMPX), 2seventy bio (TSVT), and Terns Pharmaceuticals (TERN). These companies are all part of the "pharmaceutical products" industry. Caribou Biosciences vs. Cryoport Astria Therapeutics Aquestive Therapeutics Aura Biosciences Palvella Therapeutics iTeos Therapeutics Aurora Cannabis Compass Therapeutics 2seventy bio Terns Pharmaceuticals Cryoport (NASDAQ:CYRX) and Caribou Biosciences (NASDAQ:CRBU) are both small-cap transportation companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, risk, community ranking, valuation, profitability, earnings, institutional ownership, dividends and media sentiment. Do institutionals & insiders have more ownership in CYRX or CRBU? 92.9% of Cryoport shares are owned by institutional investors. Comparatively, 77.5% of Caribou Biosciences shares are owned by institutional investors. 10.1% of Cryoport shares are owned by company insiders. Comparatively, 9.5% of Caribou Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more risk & volatility, CYRX or CRBU? Cryoport has a beta of 1.81, indicating that its stock price is 81% more volatile than the S&P 500. Comparatively, Caribou Biosciences has a beta of 2.36, indicating that its stock price is 136% more volatile than the S&P 500. Which has better valuation & earnings, CYRX or CRBU? Cryoport has higher revenue and earnings than Caribou Biosciences. Cryoport is trading at a lower price-to-earnings ratio than Caribou Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCryoport$228.39M1.23-$99.59M-$2.49-2.26Caribou Biosciences$9.99M7.93-$102.07M-$1.65-0.52 Does the MarketBeat Community favor CYRX or CRBU? Cryoport received 224 more outperform votes than Caribou Biosciences when rated by MarketBeat users. Likewise, 65.88% of users gave Cryoport an outperform vote while only 62.79% of users gave Caribou Biosciences an outperform vote. CompanyUnderperformOutperformCryoportOutperform Votes25165.88% Underperform Votes13034.12% Caribou BiosciencesOutperform Votes2762.79% Underperform Votes1637.21% Do analysts rate CYRX or CRBU? Cryoport presently has a consensus target price of $11.67, suggesting a potential upside of 107.59%. Caribou Biosciences has a consensus target price of $9.33, suggesting a potential upside of 995.08%. Given Caribou Biosciences' stronger consensus rating and higher probable upside, analysts plainly believe Caribou Biosciences is more favorable than Cryoport.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cryoport 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Caribou Biosciences 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is CYRX or CRBU more profitable? Cryoport has a net margin of -70.08% compared to Caribou Biosciences' net margin of -1,290.81%. Cryoport's return on equity of -13.35% beat Caribou Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Cryoport-70.08% -13.35% -6.43% Caribou Biosciences -1,290.81%-45.46%-38.07% Does the media refer more to CYRX or CRBU? In the previous week, Caribou Biosciences had 4 more articles in the media than Cryoport. MarketBeat recorded 7 mentions for Caribou Biosciences and 3 mentions for Cryoport. Cryoport's average media sentiment score of 0.63 beat Caribou Biosciences' score of 0.00 indicating that Cryoport is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cryoport 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Caribou Biosciences 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral SummaryCryoport beats Caribou Biosciences on 10 of the 17 factors compared between the two stocks. Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRBU vs. The Competition Export to ExcelMetricCaribou BiosciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$79.27M$2.96B$5.51B$7.84BDividend YieldN/A1.89%5.11%4.23%P/E Ratio-0.5229.8222.4018.52Price / Sales7.93492.56399.74103.35Price / CashN/A168.6838.1834.62Price / Book0.203.196.744.24Net Income-$102.07M-$72.17M$3.22B$248.05M7 Day Performance1.99%4.77%4.33%5.03%1 Month Performance-9.24%-1.82%-0.82%1.69%1 Year Performance-77.45%-21.42%16.67%4.20% Caribou Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRBUCaribou Biosciences2.5219 of 5 stars$0.85+10.4%$9.33+995.1%-79.2%$79.27M$9.99M-0.52100Upcoming EarningsAnalyst ForecastGap UpCYRXCryoport2.4097 of 5 stars$5.70-1.0%$11.67+104.7%-65.2%$284.49M$228.39M-1.691,020ATXSAstria Therapeutics2.6386 of 5 stars$4.96-4.1%$26.60+436.3%-44.9%$279.91MN/A-2.3730Analyst ForecastNews CoveragePositive NewsGap UpAQSTAquestive Therapeutics1.5579 of 5 stars$2.83-1.4%$10.67+276.9%-30.5%$279.81M$57.56M-6.29160Upcoming EarningsAURAAura Biosciences2.1679 of 5 stars$5.51+2.4%$22.75+312.9%-23.7%$276.74MN/A-3.1850Short Interest ↑PVLAPalvella Therapeutics3.4308 of 5 stars$24.57-3.2%$44.43+80.8%N/A$270.74M$42.81M-2.03N/APositive NewsITOSiTeos Therapeutics2.3162 of 5 stars$7.07-3.8%$25.75+264.2%-34.5%$270.03M$35M-2.2490Earnings ReportAnalyst ForecastNews CoverageACBAurora Cannabis0.5251 of 5 stars$4.68-2.7%N/A-30.1%$263.08M$320.81M93.621,340CMPXCompass Therapeutics3.3757 of 5 stars$1.90-2.1%$13.38+603.9%+31.0%$262.74M$850,000.00-5.1320Analyst ForecastShort Interest ↑TSVT2seventy bio1.75 of 5 stars$4.99+0.2%$5.60+12.2%+17.3%$261.17M$37.86M-2.68440Upcoming EarningsShort Interest ↑TERNTerns Pharmaceuticals4.2603 of 5 stars$2.94+0.7%$18.38+525.0%-40.1%$256.66MN/A-2.4940Positive News Related Companies and Tools Related Companies Cryoport Competitors Astria Therapeutics Competitors Aquestive Therapeutics Competitors Aura Biosciences Competitors Palvella Therapeutics Competitors iTeos Therapeutics Competitors Aurora Cannabis Competitors Compass Therapeutics Competitors 2seventy bio Competitors Terns Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CRBU) was last updated on 4/29/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Caribou Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRBU Stock Free CRBU Stock Alerts